![](/img/cover-not-exists.png)
An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay–Sachs or Sandhoff variants)
Joe T.R. Clarke, Don J. Mahuran, Swati Sathe, Edwin H. Kolodny, Brigitte A. Rigat, Julian A. Raiman, Michael B. TropakVolume:
102
Year:
2011
Language:
english
DOI:
10.1016/j.ymgme.2010.09.004
File:
PDF, 340 KB
english, 2011